NCT01132716已完成不适用
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- bioequivalence determined by statistical comparison Cmax
研究概览
简要总结
The objective of this study was to prove the bioequivalence of Valacyclovir Hydrochlorothiazide Caplet under fed conditions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening
排除标准
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •History of allergic or adverse response to valacyclovir hydrochloride or any comparable or similar product.
结局指标
主要结局
bioequivalence determined by statistical comparison Cmax
时间窗: 8 days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting ConditionsHerpes ZosterGenital HerpesShinglesNCT01132729Roxane Laboratories48
已完成
1 期
Valacyclovir 1000 mg Tablet Under Fasting ConditionsHealthyNCT01149499Teva Pharmaceuticals USA60
已完成
不适用
Bioequivalency Study of Clarithromycin Tablets Under Fasting ConditionsInfectionNCT00601315Roxane Laboratories40
已完成
不适用
Bioequivalency Study of Clarithromycin Tablets Under Fed ConditionsInfectionNCT00602498Roxane Laboratories28
已完成
3 期
Evaluation Of Valaciclovir In Patients With ChickenpoxVaricellaNCT00169416GlaxoSmithKline43